ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesAcute Coronary SyndromesLipid DisordersHeart Failure
Chest pain: Risks of evaluation may outweigh benefitsMay 18, 2015Acute Coronary SyndromesCAD & Atherosclerosis
SAEM: STEMI in the ED: Will lower incidence threaten timely care?May 15, 2015Acute Coronary Syndromes
Ultrasound accurately predicts trauma thoracotomy survivalMay 12, 2015Acute Coronary SyndromesInterventional Cardiology & Surgery
Applications expand for vorapaxar in cardiovascular preventionMay 2, 2015Acute Coronary SyndromesStroke
Testosterone therapy has neutral cardiovascular effectsApril 23, 2015Lipid DisordersAcute Coronary SyndromesCAD & Atherosclerosis
Unrecognized diabetes common in acute MIApril 21, 2015Acute Coronary SyndromesLipid DisordersDiabetes
FDA panel cautiously backs approval of short-acting IV antiplatelet drugApril 15, 2015Acute Coronary SyndromesInterventional Cardiology & SurgeryStrokeThrombosisBusiness of Medicine
Costs a wash between CTA and functional chest pain testingApril 13, 2015Acute Coronary SyndromesCAD & AtherosclerosisImaging
Thrombectomy fails to improve PCI outcomes, ups stroke riskApril 11, 2015Acute Coronary SyndromesInterventional Cardiology & SurgeryStroke
Bivalirudin edges unfractionated heparin for PCI in acute coronary syndrome patientsApril 2, 2015Acute Coronary SyndromesInterventional Cardiology & SurgeryThrombosis
